Drug intelligence / Profile preview

methicillin acyl-serine

Development stage
Unknown
Modality
Small Molecules
01

Overview

Methicillin acyl-serine is an experimental small molecule derivative related to methicillin. It is a synthetic compound with the molecular formula C20H25N3O9S and a molecular weight of approximately 483.5 g/mol[1][3]. The structure features a thiazolidine ring and an acylated serine moiety[10]. While detailed pharmacological data are not available for this specific compound in clinical use or trials[1], it is likely designed as a mechanistic probe or intermediate for studying beta-lactam antibiotics such as methicillin. Methicillin itself acts by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), particularly transpeptidases involved in peptidoglycan cross-linking[4][7]. The "acyl-serine" motif suggests this molecule may mimic the covalent intermediate formed between beta-lactams and serine residues in PBPs or beta-lactamase enzymes.

Other names
(2S)-2-amino-3-(((2R)-2-((2R,4S)-4-carboxy-5,5-dimethyl-1,3-thiazolidin-2-yl)-2-(((2,6-dimethoxyphenyl)(oxido)methylidene)amino)acetyl)oxy)propanoate(2S)-2-amino-3-{[(2R)-2-[(2R,4S)-4-carboxy-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-{[(2,6-dimethoxyphenyl)(oxido)methylidene]amino}acetyl]oxy}propanoateDB02443DB-02443DB 02443
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on methicillin acyl-serine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methicillin acyl-serine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call